Q3 2025 Holdings
Filed 2025-11-14 | 72 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $171.8M | 225,139 | 13.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $93.7M | 461,654 | 7.2% |
| Spdr Series Trust(XBI)Call | S&P BIOTECH | 78464A870 | $71.9M | 717,400 | 5.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $64.4M | 530,332 | 5.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $55.9M | 72,313 | 4.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $49.4M | 195,085 | 3.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $40.1M | 95,650 | 3.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $34.6M | 77,403 | 2.7% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $29.7M | 381,324 | 2.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $28.9M | 145,311 | 2.2% |
| Humana Inc(HUM)Call | COM | 444859102 | $28.6M | 110,000 | 2.2% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $28.0M | 65,773 | 2.2% |
| CVS Health Corp(CVS) | COM | 126650100 | $26.1M | 346,679 | 2.0% |
| Cencora Inc(COR) | COM | 03073E105 | $25.2M | 80,493 | 1.9% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $24.4M | 1,729,921 | 1.9% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $23.8M | 116,260 | 1.8% |
| Icon PLC(ICLR) | SHS | G4705A100 | $23.4M | 133,683 | 1.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $20.5M | 574,360 | 1.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $19.8M | 236,468 | 1.5% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $19.6M | 60,776 | 1.5% |
| Natera Inc(NTRA) | COM | 632307104 | $18.6M | 115,596 | 1.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $17.3M | 1,181,011 | 1.3% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $17.0M | 2,208,530 | 1.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $17.0M | 327,174 | 1.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $16.5M | 243,401 | 1.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $16.2M | 666,196 | 1.2% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $15.7M | $11,515,000 | 1.2% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $15.5M | 820,642 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $15.5M | 331,069 | 1.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $14.9M | 513,685 | 1.1% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $14.1M | 21,210 | 1.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $13.7M | 56,700 | 1.1% |
| Indivior PLC(INDV) | ORD | G4766E116 | $13.5M | 561,526 | 1.0% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $12.4M | 41,503 | 1.0% |
| Merus N V | COM | N5749R100 | $12.3M | 130,742 | 0.9% |
| Boston Scientific Corp(BSX)Call | COM | 101137107 | $11.9M | 122,000 | 0.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $11.8M | 248,079 | 0.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $11.2M | 19,890 | 0.9% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $11.2M | 64,998 | 0.9% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $9.5M | 1,662,836 | 0.7% |
| Waters Corp(WAT) | COM | 941848103 | $9.2M | 30,751 | 0.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $8.6M | 80,416 | 0.7% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $8.1M | 239,644 | 0.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $8.0M | 57,246 | 0.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $7.2M | 356,818 | 0.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.8M | 360,460 | 0.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $6.4M | 157,874 | 0.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.9M | 436,156 | 0.5% |
| Cooper COS Inc(COO) | COM | 216648501 | $5.1M | 74,363 | 0.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $4.9M | 48,162 | 0.4% |